SLNSW-Phase 1 trial of avelumab (anti-PD-L1) in Japanes...-TN_cdi_proquest_journals_2149463519

Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

Full title: Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

Author/creator: Doi, Toshihiko, Iwasa, Satoru, Muro, Kei, Satoh, Taroh, Hironaka, Shuichi, Esaki, Taito, Nishina, Tomohiro, Hara, Hiroki, Machida, Nozomu, Komatsu, Yoshito, Shimada, Yasuhiro, Otsu, Satoshi, Shimizu, Shin, Watanabe, Morihiro.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2149463519

Language: English

Formats: Articles

Publishers: Singapore: Springer Singapore

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2149463519

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

    Record identifier

    TN_cdi_proquest_journals_2149463519

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2149463519

    Share

    Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2149463519

    Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

    Full title

    Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial

    Author / Creator

    Doi, Toshihiko ; Iwasa, Satoru ; Muro, Kei ; Satoh, Taroh ; Hironaka, Shuichi ; Esaki, Taito ; Nishina, Tomohiro ; Hara, Hiroki ; Machida, Nozomu ; Komatsu, Yoshito ; Shimada, Yasuhiro ; Otsu, Satoshi ; Shimizu, Shin ; Watanabe, Morihiro

    Publisher

    Singapore: Springer Singapore

    Journal title

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019, Vol.22 (4), p.817-827

    Record Identifier

    TN_cdi_proquest_journals_2149463519

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Abdominal Surgery Adenocarcinoma Adenocarcinoma - drug therapy Adenocarcinoma - pathology Adult Aged Alanine Alanine transaminase Antibodies, Monoclonal - pharmacokinetics Antibodies, Monoclonal - therapeutic use Antitumor activity Avelumab B7-H1 Antigen - antagonists & inhibitors Cancer Cancer Research Cancer therapies Care and treatment Chemotherapy Cohort Studies Complications and side effects Dose-Response Relationship, Drug Esophageal Neoplasms - drug therapy Esophageal Neoplasms - pathology Esophagogastric Junction - drug effects Esophagogastric Junction - pathology Female Follow-Up Studies Gastric cancer Gastroenterology Humans Hyponatremia Immunoglobulin G Immunotherapy Japan Male Maximum Tolerated Dose Medicine Medicine & Public Health Metastases Metastasis Middle Aged Monoclonal antibodies Oncology Original Original Article Patients PD-L1 PD-L1 protein Phase 1 Platinum Prognosis Solid tumors Stomach cancer Stomach Neoplasms - drug therapy Stomach Neoplasms - pathology Surgical Oncology Survival Rate Targeted cancer therapy Tissue Distribution Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2149463519

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2149463519

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections